Loading...

Stock Performance

Data Provided by Refinitiv. Minimum 15 minutes delayed.


lan灯 下载

July 31, 2020 - Apellis Pharmaceuticals Reports Second Quarter 2020 Financial Results July 7, 2020 - Apellis Completes Enrollment in Two Phase 3 Studies of the Targeted C3 Therapy, Pegcetacoplan, in Patients with Geographic Atrophy (GA) July 2, 2020 - Apellis Completes Enrollment in Phase 3 Study of Pegcetacoplan in Treatment-Naïve Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH)

lan灯 下载

lan灯 下载

Investor Relations:
Argot Partners
Sam Martin / Maghan Meyers
(212) 600-1902
Email: sam@argotpartners.com / maghan@argotpartners.com

Media Relations:
Tracy Vineis
(617) 420-4839
Email: media@apellis.com

lan灯 下载

Sign up to receive email alerts whenever Apellis Pharmaceuticals, Inc. posts new information to the site. Just enter your email address and click Submit.

Sign Up
加速网络连接 Email Alerts RSS Feeds Contact IR
好用的梯子ios   推特免费永久加速器   免费加速器安卓 vp   w加速器安卓下载   小语加速器手机版官网   vivo登ins教程